<DOC>
	<DOCNO>NCT02112357</DOCNO>
	<brief_summary>This study assess feasibility sequence locally advanced/metastatic gastrointestinal cancer real-time enable future treatment stratification molecular characteristic . Targeted next generation sequence panel gene perform tumour specimen result discuss Sequencing Tumour Board establish patient potentially suitable targeted therapy .</brief_summary>
	<brief_title>Feasibility Molecular Characterisation Approach Treatment</brief_title>
	<detailed_description />
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<criteria>1 . Locally advanced metastatic gastrointestinal cancer ( include oesophageal , oesophagogastric junction , gastric , pancreatic , biliary colorectal cancer ) . 2 . Histological cytological confirmation diagnosis malignancy . 3 . Patients must either : 1 . Have receive least one line treatment locally advanced/metastatic disease OR 2 . Be start/currently undergo first line treatment locally advanced/metastatic disease 4 . 18 year age . 5 . Performance status less equal 2 . 6 . Able provide fully inform consent . 7 . Patients must either : 1 . Have available tumour specimen ( FFPE fresh frozen ) either primary tumour metastasis . Metastatic sample may site exception bone . OR 2 . Have site disease amendable biopsy There specific exclusion criterion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>molecular profiling</keyword>
	<keyword>genetic sequencing</keyword>
	<keyword>personalised medicine</keyword>
	<keyword>gastrointestinal cancer</keyword>
</DOC>